Floatz logo

PARAFFINUM FLAVUM

Radiation-Induced Dermatitis

OHSU Knight Cancer InstitutemixturePhase 1/2Active
CC
43/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
28/ 100
Competitive Position
95/ 100

Competitive context

5 Active assets in the Radiation-Induced Dermatitis cohort.

Asset / SponsorPhaseRating
Curcumin-Based Gel
Gary Morrow
Phase 2B
Solu-Cortef
OHSU Knight Cancer Institute
N/AD
LANOLIN
OHSU Knight Cancer Institute
N/AD
MINERAL OIL (HIGH VISCOSITY)
OHSU Knight Cancer Institute
N/AD
Sulfadiazine
OHSU Knight Cancer Institute
N/AD
Calendula
OHSU Knight Cancer Institute
N/AD

Same molecule, other indications

PARAFFINUM FLAVUM is also rated in:

Breast Ductal Carcinoma In SituDormant
CC
Indicative ·
40 / 100
View asset →
Invasive Breast CarcinomaDormant
CC
Indicative ·
40 / 100
View asset →
Breast CarcinomaDormant
D
Indicative ·
30 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →